These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37244870)

  • 21. Survey of perceptions and practices among Canadian gastroenterologists regarding the prevention of venous thromboembolism for hospitalized inflammatory bowel disease patients.
    Razik R; Bernstein CN; Sam J; Thanabalan R; Nguyen GC
    Can J Gastroenterol; 2012 Nov; 26(11):795-8. PubMed ID: 23166902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Venous Thromboembolism Prophylaxis in Pediatric Inflammatory Bowel Disease Patients Hospitalized With a Central Line.
    Hamant LG; Gonzalez-Llanos L; Patel AS; McMahon L; Knoll C; Swing T; Pasternak B
    J Pediatr Gastroenterol Nutr; 2023 May; 76(5):610-615. PubMed ID: 36821846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Venous Thromboembolism in Children with Inflammatory Bowel Disease: When is the Right Time for Thromboprophylaxis?
    Torrente F; Hansen R
    J Crohns Colitis; 2022 Jun; 16(5):691-692. PubMed ID: 34979551
    [No Abstract]   [Full Text] [Related]  

  • 24. Venous thromboembolism in patients with inflammatory bowel disease: focus on prevention and treatment.
    Papa A; Gerardi V; Marzo M; Felice C; Rapaccini GL; Gasbarrini A
    World J Gastroenterol; 2014 Mar; 20(12):3173-9. PubMed ID: 24695669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of prophylaxis and treatment for hospitalized patients associated with venous thromboembolism.
    Yang Y; Li X; Zhai Z; Shen D; Han L; Tang P;
    Chin Med J (Engl); 2023 May; 136(9):1111-1113. PubMed ID: 37052147
    [No Abstract]   [Full Text] [Related]  

  • 26. Genetic risk stratification of inflammatory bowel disease-associated venous thromboembolism: An Asian perspective.
    Huang JG
    World J Gastroenterol; 2024 Mar; 30(9):1250-1252. PubMed ID: 38577175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of venous thromboembolism in patients with chronic liver disease and the utility of venous thromboembolism prophylaxis.
    Pincus KJ; Tata AL; Watson K
    Ann Pharmacother; 2012 Jun; 46(6):873-8. PubMed ID: 22570429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Venous thromboembolism in inflammatory bowel disease.
    Cheng K; Faye AS
    World J Gastroenterol; 2020 Mar; 26(12):1231-1241. PubMed ID: 32256013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Venous thromboembolism in patients with inflammatory bowel disease: review of literature and practical algorithms.
    Coremans L; Strubbe B; Peeters H
    Acta Gastroenterol Belg; 2021; 84(1):79-85. PubMed ID: 33639697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disease activity and venous thromboembolism in inflammatory bowel disease.
    Thachil J
    Lancet; 2010 May; 375(9727):1689; author reply 1690-1. PubMed ID: 20472160
    [No Abstract]   [Full Text] [Related]  

  • 31. Hospital performance for pharmacologic venous thromboembolism prophylaxis and rate of venous thromboembolism : a cohort study.
    Flanders SA; Greene MT; Grant P; Kaatz S; Paje D; Lee B; Barron J; Chopra V; Share D; Bernstein SJ
    JAMA Intern Med; 2014 Oct; 174(10):1577-84. PubMed ID: 25133488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and factors associated with the absence of pharmacologic venous thromboembolism prophylaxis: A cross-sectional study of Georgia intensive care units.
    Hawkins A; Mazzeffi M; Abraham P; Paciullo C
    J Crit Care; 2016 Dec; 36():49-53. PubMed ID: 27546747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thrombosis in inflammatory bowel disease: are we tailoring prophylaxis to those most at risk?
    Bryant RV; Jairath V; Curry N; Travis SP
    J Crohns Colitis; 2014 Feb; 8(2):166-71. PubMed ID: 24095288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of pharmacologic prophylaxis for venous thromboembolism in patients with chronic liver disease.
    Barclay SM; Jeffres MN; Nguyen K; Nguyen T
    Pharmacotherapy; 2013 Apr; 33(4):375-82. PubMed ID: 23553808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Venous Thromboembolism Risk in Asian Patients with Inflammatory Bowel Disease: A Population-Based Nationwide Inception Cohort Study.
    Kim SY; Cho YS; Kim HS; Lee JK; Kim HM; Park HJ; Kim H; Kim J; Kang DR
    Gut Liver; 2022 Jul; 16(4):555-566. PubMed ID: 34789583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Venous thromboembolism with inflammatory bowel disease.
    Freeman HJ
    World J Gastroenterol; 2008 Feb; 14(7):991-3. PubMed ID: 18286676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pediatric Gastroenterologists' Approach to Venous Thromboembolism Prophylaxis in Pediatric Inflammatory Bowel Disease.
    Chien KA; Hammad HT; Gerber L; Sheth S; Sockolow R; Kucine N
    J Pediatr Gastroenterol Nutr; 2018 Feb; 66(2):286-288. PubMed ID: 28742719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patterns and outcomes of prescribing venous thromboembolism prophylaxis in hospitalized older adults: a retrospective cohort study.
    Goldin M; Cohen J; Makhnevich A; Mulvany C; Akerman M; Sinvani L
    J Thromb Thrombolysis; 2018 Apr; 45(3):369-376. PubMed ID: 29330739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prophylaxis against venous thromboembolism in hospitalized medical patients: an evidence-based and practical approach.
    Douketis JD; Moinuddin I
    Pol Arch Med Wewn; 2008 Apr; 118(4):209-15. PubMed ID: 18575420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A cross-sectional evaluation of venous thromboembolism risk and use of venous thromboembolism prophylaxis in hospitalized patients in Senegal.
    Bâ SA; Badiane SB; Diop SN; Diouf FS; Fall D; Ka MM; Kane A; Ndiaye M;
    Arch Cardiovasc Dis; 2011 Oct; 104(10):493-501. PubMed ID: 22044701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.